Connection

EMERSON PERIN to Magnetic Resonance Imaging

This is a "connection" page, showing publications EMERSON PERIN has written about Magnetic Resonance Imaging.
Connection Strength

0.401
  1. Assessing myocardial viability and infarct transmurality with left ventricular electromechanical mapping in patients with stable coronary artery disease: validation by delayed-enhancement magnetic resonance imaging. Circulation. 2002 Aug 20; 106(8):957-61.
    View in: PubMed
    Score: 0.089
  2. A New High-Performance Gadonanotube-Polymer Hybrid Material for Stem Cell Labeling and Tracking by MRI. Contrast Media Mol Imaging. 2018; 2018:2853736.
    View in: PubMed
    Score: 0.067
  3. Surfactant-free Gd(3+)-ion-containing carbon nanotube MRI contrast agents for stem cell labeling. Nanoscale. 2015 Jul 28; 7(28):12085-91.
    View in: PubMed
    Score: 0.054
  4. Rationale and design for PACE: patients with intermittent claudication injected with ALDH bright cells. Am Heart J. 2014 Nov; 168(5):667-73.
    View in: PubMed
    Score: 0.051
  5. Imaging long-term fate of intramyocardially implanted mesenchymal stem cells in a porcine myocardial infarction model. PLoS One. 2011; 6(9):e22949.
    View in: PubMed
    Score: 0.041
  6. TIME Trial: Effect of Timing of Stem Cell Delivery Following ST-Elevation Myocardial Infarction on the Recovery of Global and Regional Left Ventricular Function: Final 2-Year Analysis. Circ Res. 2018 02 02; 122(3):479-488.
    View in: PubMed
    Score: 0.016
  7. Baseline assessment and comparison of arterial anatomy, hyperemic flow, and skeletal muscle perfusion in peripheral artery disease: The Cardiovascular Cell Therapy Research Network "Patients with Intermittent Claudication Injected with ALDH Bright Cells" (CCTRN PACE) study. Am Heart J. 2017 Jan; 183:24-34.
    View in: PubMed
    Score: 0.015
  8. Bone marrow cell characteristics associated with patient profile and cardiac performance outcomes in the LateTIME-Cardiovascular Cell Therapy Research Network (CCTRN) trial. Am Heart J. 2016 09; 179:142-50.
    View in: PubMed
    Score: 0.015
  9. The use of gadolinium-carbon nanostructures to magnetically enhance stem cell retention for cellular cardiomyoplasty. Biomaterials. 2014 Jan; 35(2):720-6.
    View in: PubMed
    Score: 0.012
  10. Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial. JAMA. 2012 Dec 12; 308(22):2380-9.
    View in: PubMed
    Score: 0.011
  11. CD34(+) cell infusion after ST elevation myocardial infarction is associated with improved perfusion and is dose dependent. Am Heart J. 2011 Jan; 161(1):98-105.
    View in: PubMed
    Score: 0.010
  12. Gadonanotubes as magnetic nanolabels for stem cell detection. Biomaterials. 2010 Dec; 31(36):9482-91.
    View in: PubMed
    Score: 0.010
  13. LateTIME: a phase-II, randomized, double-blinded, placebo-controlled, pilot trial evaluating the safety and effect of administration of bone marrow mononuclear cells 2 to 3 weeks after acute myocardial infarction. Tex Heart Inst J. 2010; 37(4):412-20.
    View in: PubMed
    Score: 0.009
  14. Detection of thrombus in an aneurysm of the ventricular septum. Am J Cardiol. 1989 Jun 15; 63(20):1533-5.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.